Safety of Modified Dust Mite Subcutaneous Immunotherapy in Severe Allergic Asthma

被引:0
|
作者
Gonzalez, Ruperto [1 ]
Poza, Paloma [2 ]
Matheu, Victor [3 ]
Sanchez-Machin, Inmaculada [4 ]
机构
[1] Hosp Ofra Torax, Santa Cruz de Tenerife, Spain
[2] Hosp Ofra Torax, Santa Cruz De Tenerife, Spain
[3] Hosp Ofra, Tenerife, Spain
[4] Hosp Ofra Torax, Tenerife, Spain
关键词
D O I
10.1016/j.jaci.2012.12.1400
中图分类号
R392 [医学免疫学];
学科分类号
100102 ;
摘要
引用
收藏
页码:AB205 / AB205
页数:1
相关论文
共 50 条
  • [21] Analysis of adverse reactions induced by subcutaneous immunotherapy to dust mite - a retrospective study on 234 cases with allergic rhinitis and asthma
    Li, M.
    Wang, X.
    Lin, J.
    Zhang, H.
    Jin, K.
    Li, Y.
    Li, C.
    ALLERGY, 2011, 66 : 300 - 300
  • [22] Use of omalizumab prior to immunotherapy in a patient with a severe asthma allergic to mite
    de Blay, F.
    Bloch, Y.
    Purohit, A.
    Darouaz, S.
    ALLERGY, 2011, 66 : 626 - 626
  • [23] Early effectiveness of allergen immunotherapy in children with asthma allergic to house dust mite
    Sobocinska, Agnieszka
    Majak, Pawel
    Jerzynska, Joanna
    Ozarek-Hanc, Agata
    Stelmach, Iwona
    ALERGIA ASTMA IMMUNOLOGIA, 2012, 17 (01): : 27 - 31
  • [24] Association between biomarkers and house dust mite sublingual immunotherapy in allergic asthma
    Hoshino, Makoto
    Akitsu, Kenta
    Kubota, Kengo
    Ohtawa, Junichi
    CLINICAL AND EXPERIMENTAL ALLERGY, 2020, 50 (09): : 1035 - 1043
  • [25] Sublingual dust mite immunotherapy for asthma
    Harding, Emilia
    LANCET RESPIRATORY MEDICINE, 2016, 4 (06): : 436 - 436
  • [26] Efficacy and safety of subcutaneous immunotherapy with house dust mite for allergic rhinitis: A Meta-analysis of Randomized Controlled Trials
    Huang, Yanran
    Wang, Chengshuo
    Wang, Xiangdong
    Zhang, Luo
    Lou, Hongfei
    ALLERGY, 2019, 74 (01) : 189 - 192
  • [27] Comparison of subcutaneous and sublingual immunotherapy in house dust mite-induced allergic rhinitis
    Lee, Sang Min
    ALLERGY ASTHMA & RESPIRATORY DISEASE, 2024, 12 (01): : 1 - 2
  • [28] Efficacy and safety of subcutaneous immunotherapy in asthmatic children allergic to house dust mite: a meta-analysis and systematic review
    Zheng, Chen
    Xu, Hao
    Huang, Shumin
    Chen, Zhimin
    FRONTIERS IN PEDIATRICS, 2023, 11
  • [29] High level of adherence and clinical improvement in daily practice in allergic asthma with subcutaneous high-dose modified hypoallergenic house dust mite preparations immunotherapy
    Gonzalez-Perez, R.
    Poza-Guedes, P.
    Matheu-Delgado, V
    Sanchez-Macin, I
    Subtil-Rodriguez, A.
    Rosales-Fletes, M. J.
    ALLERGY, 2016, 71 : 514 - 514
  • [30] Comparision Between Treatment Persistence With Omalizumab in Severe Allergic Asthma and Subcutaneous Immunotherapy in Severe Allergic Rhinitis
    Ozseker, Zeynep
    Bulut, Ismet
    Erdogdu, Derya
    Gelincik, Asli
    Erdenen, Fusun
    Ersoy, Ramazan
    Kutlu, Ali
    Talay, Fahrettin
    Colakoglu, Bahattin
    Buyukozturk, Suna
    CHEST, 2013, 144 (04)